Showing results (91-100 of 142) with videos related to
Sort By:
Pageof 15
Journal of Clinical Periodontology|April 1, 2025
A Real-World Evidence Study Evaluating Oral-Health-Related Quality of Life Following the Use of Anti-Sensitivity Toothpaste for Self-Reported Dentine Hypersensitivity ManagementRoberta Grimaldi, Sarah R Baker, Parth Shah, et al.Neurourology and Urodynamics|September 19, 2019
A national UK audit of suprapubic catheter insertion practice and rate of bowel injury with comparison to a systematic review and meta-analysis of available researchS Hall, S Ahmed, S Reid, et al.The New England Journal of Medicine|June 16, 1988
Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cellsM B Atkins, J W Mier, D R Parkinson, et al.Cancer Research|December 1, 1986
Inhibitory effects of elevated temperature on human cytokine production and natural killer activityC A Dinarello, R A Dempsey, M Allegretta, et al.Clinical Oral Investigations|February 10, 2018
Effects of a sodium fluoride- and phytate-containing dentifrice on remineralisation of enamel erosive lesions-an in situ randomised clinical studyJonathan E Creeth, Charles R Parkinson, Gary R Burnett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomasJ H Edmonson, L M Ryan, R H Blum, et al.Cancer Research|September 1, 1990
Clonal analysis of lymphocytes from tumor, peripheral blood, and nontumorous kidney in primary renal cell carcinomaT Y Kim, A C von Eschenbach, M D Filaccio, et al.Life Sciences|January 3, 1983
On the nature of the genes influencing the prevalence of Graves' diseaseD D Adams, Y J Adams, J G Knight, et al.Blood|May 15, 1992
Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptorC F LeMaistre, C Meneghetti, M Rosenblum, et al.Lancet (London, England)|May 28, 1977
Complications of cancer immunotherapy with levamisoleD R Parkinson, P O Cano, L M Jerry, et al.Pageof 15